Viatris

Viatris is a global healthcare company formed in 2020 through the merger of Mylan and Upjohn, the latter being Pfizer's off-patent branded and generic medicines division. The company focuses on making healthcare accessible worldwide by offering a diverse portfolio of over 1,400 approved molecules in more than 165 countries, spanning therapeutic areas such as cardiovascular, metabolic, respiratory, and central nervous system conditions. With a strong focus on patient health, Viatris is a major player in the global pharmaceutical industry, employing more than 35,000 people worldwide.

In Spain, Viatris maintains a significant presence with one of its largest European operations located in Barcelona, serving as a regional hub for areas such as regulatory, medical, and digital innovation. The company's Spanish site is a center for its commercial and technical operations, reflecting a collaborative and innovative work culture. For international professionals, Viatris in Spain offers roles that support a diverse and multicultural workforce, with opportunities across biomedical, digital, and business functions, making it an attractive employer for those seeking to advance their careers in the pharmaceutical sector in a country with a strong industry presence.